BOSS ZHIPIN-W
02076
TME-SW
01698
NTES-S
09999
4
JD HEALTH
06618
5
BIDU-SW
09888
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ---- | -6.17%1.46B | ---- | 11.59%4.39B | ---- | 13.43%1.56B | ---- | -7.12%3.93B | ---- | 18.50%1.37B |
Special items of operating revenue | -12.74%3.01B | ---- | -48.25%510.37M | ---- | 19.87%3.44B | ---- | 10.39%986.28M | ---- | 4.80%2.87B | ---- |
Operating income | -12.74%3.01B | -6.17%1.46B | -48.25%510.37M | 11.59%4.39B | 19.87%3.44B | 13.43%1.56B | 10.39%986.28M | -7.12%3.93B | 4.80%2.87B | 18.50%1.37B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Administrative expenses | 3.60%-1.56B | ---- | -18.62%-470M | ---- | -31.77%-1.62B | ---- | -2.59%-396.24M | ---- | -8.57%-1.23B | ---- |
Employee expense | ---- | 12.60%-633.13M | ---- | -24.57%-1.38B | ---- | -44.75%-724.45M | ---- | 11.92%-1.11B | ---- | -24.48%-500.49M |
Depreciation and amortization | ---- | -28.73%-152.79M | ---- | -40.91%-270.53M | ---- | -28.30%-118.69M | ---- | -10.30%-191.99M | ---- | -8.14%-92.51M |
Impairment and provision | -9.41%19.76M | -85.55%1.26M | -94.18%94.44K | 1,175.92%28.6M | 382.43%21.81M | 13.75%8.7M | -47.90%1.62M | 91.02%-2.66M | 75.61%-7.72M | 138.55%7.64M |
-Other impairment is provision | -9.41%19.76M | -85.55%1.26M | -94.18%94.44K | 1,175.92%28.6M | 382.43%21.81M | 13.75%8.7M | -47.90%1.62M | 91.02%-2.66M | 75.61%-7.72M | 138.55%7.64M |
Operating interest expense | -6.78%-1B | -11.68%-671.38M | -9.43%-336.95M | ---- | -14.46%-937.08M | -10.98%-601.16M | -19.59%-307.9M | ---- | -19.01%-818.67M | -29.70%-541.69M |
Special items of operating profit | ---- | -93.98%37.62M | ---- | -17.64%-671.3M | ---- | 118.69%624.53M | ---- | 13.41%-570.64M | ---- | 8.64%285.58M |
Operating profit | -49.73%448.04M | -94.27%42.73M | -208.01%-300.07M | 1.74%2.1B | 11.20%891.19M | 40.41%746.13M | 10.91%277.81M | 75.77%2.06B | -8.20%801.45M | 7.08%531.41M |
Financing cost | ---- | ---- | ---- | -14.80%-1.25B | ---- | ---- | ---- | ---1.09B | ---- | ---- |
Share of profits of associates | ---- | 216.24%1.62M | ---- | -243.84%-21.03M | ---- | -90.37%511K | ---- | -371.18%-6.12M | ---- | 66.74%5.31M |
Special items of earning before tax | ---- | -17.29%10.19M | ---- | ---- | ---- | 37.80%12.31M | ---- | ---- | ---- | -2.56%8.94M |
Adjustment items of earning before tax | 7,097.79%4.34M | ---- | 565.84%662.48K | ---- | -98.05%60.35K | ---- | 157.35%99.5K | ---- | 790.43%3.09M | ---- |
Earning before tax | -49.24%452.38M | -92.82%54.53M | -207.73%-299.41M | -14.50%825.42M | 10.78%891.26M | 39.09%758.96M | 11.03%277.91M | -17.72%965.43M | -7.89%804.53M | 7.28%545.65M |
Tax | 69.48%-50.52M | 122.85%36.09M | 217.28%82.76M | 23.86%-150.87M | -2.83%-165.55M | -45.66%-157.92M | -14.83%-70.57M | 30.41%-198.15M | 25.64%-161M | 16.38%-108.42M |
After-tax profit from continuing operations | -44.62%401.86M | -84.92%90.62M | -204.49%-216.65M | -12.09%674.55M | 12.77%725.7M | 37.46%601.04M | 9.79%207.35M | -13.66%767.29M | -2.03%643.53M | 15.37%437.24M |
Earning after tax | -44.62%401.86M | -84.92%90.62M | -204.49%-216.65M | -12.09%674.55M | 12.77%725.7M | 37.46%601.04M | 9.79%207.35M | -13.66%767.29M | -2.03%643.53M | 15.37%437.24M |
Minority profit | 656.55%6.01M | 298.50%2.91M | --2.11M | --3.23M | ---1.08M | --731K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -45.53%395.85M | -85.39%87.71M | -205.50%-218.75M | -12.51%671.32M | 12.94%726.78M | 37.30%600.31M | 9.79%207.35M | -13.66%767.29M | -2.03%643.53M | 15.37%437.24M |
Basic earnings per share | -46.15%0.14 | -85.71%0.03 | -214.29%-0.08 | -11.11%0.24 | 13.04%0.26 | 40.00%0.21 | 0.00%0.07 | -25.00%0.27 | -17.86%0.23 | -6.25%0.15 |
Diluted earnings per share | -46.15%0.14 | -214.29%-0.08 | 13.04%0.26 | 0.00%0.07 | -17.86%0.23 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.